Novartis Ag (NVS) Prepaid Assets (2009 - 2026)
Novartis Ag recorded quarterly Prepaid Assets of $100.0 million in Q1 2026, down 91.33% quarter-over-quarter from $1.2 billion in Q4 2025.
Novartis Ag's Prepaid Assets history runs 13 years deep, the most recent figure standing at $100.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets changed N/A year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $100.0 million (changed N/A YoY), while the FY2025 annual figure was $1.2 billion, up 17.06% from the prior year.
- Prepaid Assets came in at $100.0 million for Q1 2026 at Novartis Ag, down from $1.2 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.5 billion in Q2 2025 to a low of $5.0 million in Q1 2022.
- A 5-year average of $1.9 billion and a median of $2.5 billion in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets sank 62.22% in 2024 and grew 17.06% in 2025, its largest moves.
- Novartis Ag's Prepaid Assets stood at $2.5 billion in 2022, then increased by 5.5% to $2.6 billion in 2023, then tumbled by 62.22% to $985.0 million in 2024, then rose by 17.06% to $1.2 billion in 2025, then slumped by 91.33% to $100.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $100.0 million, $1.2 billion, and $3.5 billion for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 1.15 Bn |
| Jun 30, 2025 | 3.46 Bn |
| Dec 31, 2024 | 985.00 Mn |
| Jun 30, 2024 | 3.03 Bn |
| Dec 31, 2023 | 2.61 Bn |
| Jun 30, 2023 | 2.83 Bn |
| Dec 31, 2022 | 2.47 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 2.44 Bn |
| Jun 30, 2021 | 2.69 Bn |
| Dec 31, 2020 | 2.52 Bn |
| Jun 30, 2020 | 2.73 Bn |
| Dec 31, 2019 | 3.00 Mn |
| Jun 30, 2019 | 2.79 Bn |
| Mar 31, 2019 | 435.00 Mn |
| Dec 31, 2018 | 2.86 Bn |
| Sep 30, 2018 | 8.00 Mn |
| Jun 30, 2018 | 2.83 Bn |
| Dec 31, 2017 | 3.05 Bn |
| Dec 31, 2016 | 2.54 Bn |
| Mar 31, 2010 | 2,471.00 |
| Dec 31, 2009 | 2,102.00 |
| Sep 30, 2009 | 2,149.00 |
| Jun 30, 2009 | 2,060.00 |
| Mar 31, 2009 | 2,128.00 |